Key Takeaways
- The company reduced its annual dividend by half, dropping from $1.40 to $0.70 per share
- Fiscal 2027 earnings per share forecast of $1.40ā$1.50 fell short of the $1.59 analyst consensus
- A $2 billion impairment charge led to a quarterly net loss of $1.6 billion
- Organic revenue is projected to contract 1%ā3% in FY2027, a steeper decline than the 0.4% reduction in FY2026
- Shares dropped approximately 4%ā5.5% in early trading and have declined roughly 18% year-to-date
Conagra Brands (CAG) delivered its fourth-quarter and full fiscal 2026 earnings on Wednesday, triggering a sharp selloff as investors digested disappointing forward guidance. The stock plummeted roughly 5.5% in premarket hours to $13.37, hovering near the bottom of its 52-week trading range of $12.53 to $20.32.
At first glance, the quarterly results appeared solid. The company posted adjusted earnings per share of $0.47, beating estimates by a penny. Revenue reached $2.88 billion, marginally below the $2.89 billion consensus forecast. However, these figures weren’t the focus of investor concern.
The major blow came from the dividend announcement. Conagra reduced its annualized dividend payment by 50%, bringing it down from $1.40 to $0.70 per share. With a 51-year streak of consecutive dividend payments, this represented a significant departure from the company’s historical practice.
CEO John Brase, who assumed leadership in June, characterized the decision as a strategic recalibration. The dividend reduction is anticipated to generate approximately $335 million in annual cash flow, earmarked for debt paydown and capital improvements.
Forward Outlook Disappoints Wall Street
The fiscal 2027 projections compounded investor concerns. Conagra issued adjusted earnings guidance of $1.40 to $1.50 per share, missing the Street’s $1.59 expectation. The company anticipates organic revenue will decline 1% to 3%, representing a more pronounced contraction compared to the 0.4% drop experienced in FY2026.
Adjusted operating margin is forecast to narrow to 10.0%ā10.5%, down from the prior year’s 11.3%. The packaged foods manufacturer faces inflation pressures of 5ā6%, including tariff-related cost increases on beef, steel, and aluminum packaging materials.
The company expects its weakest performance in the first quarter of FY2027, with organic sales declining in the low-single digits and adjusted operating margin falling to the high-single digit range. Approximately $40 million in tariff-related expenses are concentrated in Q1.
The net leverage ratio is projected at roughly 4.0x for the full year before the company begins working it down toward its long-term target of 3.0x.
Massive Impairment and Strategic Overhaul
Conagra recorded a substantial $2 billion impairment charge during the quarter, attributed to the sustained decline in its stock price and overall market capitalization. This charge drove the quarterly net loss to $1.6 billion.
For the complete fiscal 2026 year, adjusted earnings per share totaled $1.72, representing a 25.2% year-over-year decrease, though it remained within the company’s previously issued guidance range. Free cash flow conversion was robust at 119%, despite absolute free cash flow declining 24.9% to $979 million.
Brase articulated four core strategic initiatives: stabilizing profit margins, boosting brand investment, streamlining the product portfolio, and restructuring capital allocation. The company plans to increase advertising and promotional expenditures to approximately 3% of net sales in FY2027, marking a 14% year-over-year increase.
Capital spending is budgeted at around $550 million for FY2027, up from $423 million in the previous fiscal year, with emphasis on modernizing supply chain infrastructure.
Intense competition from private-label brands continues to pressure sales volumes. Management noted that cost-conscious consumers, particularly those affected by elevated fuel prices, have increasingly shifted toward value-oriented alternatives.
CAG shares have declined approximately 18% since the beginning of 2026.


